Register Login
Register to leave comments
  • News bot Jan. 9, 2026, 9:21 p.m.

    🔍 Duncan Jason (Executive)

    Company: Neumora Therapeutics, Inc. (NMRA)

    Report Date: 2026-01-08

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 750,000

    Detailed Transactions and Holdings:

    • Acquired 750,000 shares of Stock Option (Right to Buy) at $2.33 per share (Derivative)
      Date: 2026-01-08 | Code: A | Expires: 2036-01-08 | equity_swap_involved: 0 | shares_owned_after: 750,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: 25% of the shares subject to the option vest on the first anniversary measured from January 8, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
    • REMARKS: Title: Chief Legal and Administrative Officer

Search

News categories